Daniel Thomas - 29 Jul 2025 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
31 Jul 2025, 17:38:29 UTC
Prior SEC filing
29 Nov 2024
Next SEC filing
06 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael E. Tarvin, Attorney-in-Fact
Filing notes and source

Key filing fact

Daniel Thomas filed Form 4 for SELECT MEDICAL HOLDINGS CORP (SEM) on 31 Jul 2025.

Key facts

  • This page summarizes Daniel Thomas's Form 4 filing for SELECT MEDICAL HOLDINGS CORP (SEM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 31 Jul 2025, 17:38.

Change

  • Previous filing in this sequence was filed on 29 Nov 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001784668 Primary reporting owner

Thomas Daniel

Relationship
Director
Address
C/O SELECT MEDICAL CORPORATION, 4714 GETTYSBURG ROAD, MECHANICSBURG
Signature
/s/ Michael E. Tarvin, Attorney-in-Fact
Signature date
31 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SEM transaction

Common Stock

Award

Transaction value
$0
Shares
+14,035
Change %
+21%
Price
$0.000000
Shares after
80,035
Date
29 Jul 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Grant of restricted stock which, subject to certain exceptions, will vest in full on July 29, 2026, the first anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .